CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Porton Pharma Solutions Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Porton Pharma Solutions Ltd
No. 7, Yuntu Road, Beibei District
Phone: +86 2365936900p:+86 2365936900 CHONGQING, CHO  400714  China Ticker: 300363300363

Business Summary
Porton Pharma Solutions Ltd is a China-based company primarily engaged in the provision of contract development manufacturing organization (CDMO) services for different types of drugs and therapies, such as small molecule drugs, large molecule drugs and gene cell therapy. The Company’s businesses include small molecule active pharmaceutical ingredient CDMO business, small molecule preparation CDMO business, gene cell therapy CDMO business, synthetic large molecule CDMO business and biological large molecule CDMO business. The Company's services are mainly used in the treatment of major diseases such as antiviral, anti-tumor and immune function regulation, anti-infection, nervous system, cardiovascular, digestive tract and metabolism, rare diseases and others. The Company conducts its business in the domestic and overseas markets.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202412/31/2023Yes---Yes

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, General Manager NianfengJu 52 2/26/2018 3/28/2016
Finance Director, Deputy General Manager HuiChen 45 4/22/2022 4/22/2022
Chief Operating Officer, Senior Deputy General Manager YinchunBai 51 1/1/2023 4/22/2022
10 additional Officers and Directors records available in full report.

Business Names
Business Name
300363
Porton Americas, Inc.

General Information
Number of Employees: 4,915 (As of 12/31/2023)
Outstanding Shares: 545,464,520 (As of 9/30/2024)
Shareholders: 56,432
Stock Exchange: SHE
Fax Number: +86 2365936901


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, January 31, 2025